Publication:
Thymic tumors and outcomes after radiotherapy

dc.contributor.authorSarıhan, Süreyya
dc.contributor.authorBayram, Ahmet Sami
dc.contributor.authorGebitekin, Cengiz
dc.contributor.authorYerci, Ömer
dc.contributor.authorÖzkan, Lütfi
dc.contributor.buuauthorSARIHAN, SÜREYYA
dc.contributor.buuauthorBAYRAM, AHMET SAMİ
dc.contributor.buuauthorGEBİTEKİN, CENGİZ
dc.contributor.buuauthorYERCİ, ÖMER
dc.contributor.buuauthorÖzkan, Lütfi
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Göğüs Cerrahisi Anabilim Dalı
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı
dc.contributor.orcid0000-0003-4816-5798
dc.contributor.orcid0000-0003-0684-0900
dc.contributor.researcheridAAE-1069-2022
dc.contributor.researcheridABB-7580-2020
dc.contributor.researcheridAAH-4970-2021
dc.contributor.researcheridEIS-5114-2022
dc.contributor.researcheridJGQ-9310-2023
dc.date.accessioned2024-11-07T08:17:00Z
dc.date.available2024-11-07T08:17:00Z
dc.date.issued2013-01-01
dc.description.abstractOBJECTIVESWe evaluated the results of treatment in patients with thymic tumors treated with postoperative adjuvant radiotherapy.METHODSEighteen patients were treated median 5400 cGy radiotherapy between 1995-2010. Diagnosis of patients were thymoma (n=10), thymic carcinoma (n=7), thymic neuroendocrin carcinoma (n=1). RO resection was made on 12 of them. According to prognostic stratification with Masaoka stage and WHO classification, there were 5 good, 7 moderate, and 6 poor risk patients. Survival was calculated from diagnosis.RESULTSA total of 33% patients were recurred median 29.5 months with 34 months follow-up. Local control, median overall and disease-free survival for all patients were 77%, 113 months, and 105 months. Local control for good, moderate, poor risk groups were found 100%, 71%, 50%. There were significant differences survival rates for Masaoka stage, RO resection, and prognostic groups.CONCLUSIONPrognostic risk classification was found to be better predictive in terms of local control and survival.
dc.identifier.doi10.5505/tjoncol.2013.904
dc.identifier.endpage66
dc.identifier.issn1300-7467
dc.identifier.issue2
dc.identifier.startpage59
dc.identifier.urihttps://doi.org/10.5505/tjoncol.2013.904
dc.identifier.urihttps://onkder.org/pdf/pdf_TOD_857.pdf
dc.identifier.urihttps://hdl.handle.net/11452/47546
dc.identifier.volume28
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherKare Yayın
dc.relation.journalTürk Onkoloji Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectThymic tumor
dc.subjectAdjuvant radiotherapy
dc.subjectLocal control
dc.subjectPrognostic group
dc.subjectSurvival
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectOncology
dc.titleThymic tumors and outcomes after radiotherapy
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication07b16629-e65c-40b0-b11d-825ad7943570
relation.isAuthorOfPublicationbdb7801d-f0bc-4abc-af2c-5bf7df23fbd5
relation.isAuthorOfPublication029ec57f-2451-4282-8110-61c87cd6a41d
relation.isAuthorOfPublication559e3ec8-742a-46d4-bf58-8bb138ca553d
relation.isAuthorOfPublication.latestForDiscovery07b16629-e65c-40b0-b11d-825ad7943570

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Sarıhan_vd_2013.pdf
Size:
1.51 MB
Format:
Adobe Portable Document Format

Collections